Journal
DIAGNOSTICS
Volume 11, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/diagnostics11112166
Keywords
pancreatic ductal adenocarcinoma; pancreatic neoplasm; computed tomography (CT); magnetic resonance imaging (MRI)
Categories
Ask authors/readers for more resources
The article discusses the increasing incidence and mortality of pancreatic ductal adenocarcinoma over time, highlighting the importance of a multidisciplinary team in the management of patients. It also covers advancements in the molecular basis of the disease, diagnostic tools for staging, and the management of resectable or borderline resectable pancreatic cancer.
The incidence and mortality of pancreatic ductal adenocarcinoma are growing over time. The management of patients with pancreatic ductal adenocarcinoma involves a multidisciplinary team, ideally involving experts from surgery, diagnostic imaging, interventional endoscopy, medical oncology, radiation oncology, pathology, geriatric medicine, and palliative care. An adequate staging of pancreatic ductal adenocarcinoma and re-assessment of the tumor after neoadjuvant therapy allows the multidisciplinary team to choose the most appropriate treatment for the patient. This review article discusses advancement in the molecular basis of pancreatic ductal adenocarcinoma, diagnostic tools available for staging and tumor response assessment, and management of resectable or borderline resectable pancreatic cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available